Treatment
Treatment 10/02/2012
Cotrimoxazole prophylaxis reduces death rate by almost 60% in adults taking ART in low and middle-income countries
Further research is needed to determine the optimum length of time for cotrimoxazole treatment in HIV-infected adults on ART.
Treatment 10/02/2012
FDA panel: Qutenza pain patch for neuropathy not ready for approval
A U.S. Food and Drug Administration advisory committee voted unanimously against recommending the approval of a novel patch applied to the soles of the feet to remedy pain associated with neuropathy in people living with HIV.
Treatment 09/02/2012
Use of some anti-HIV drugs during pregnancy linked to cleft lip and palate; investigators urge cautious interpretation of results
Further studies should be performed to assess the relative safety of the drugs and the specific conditions or potential synergies that might lead to the development of cleft lip and palate.
Treatment 08/02/2012
Conflicting data on bone fracture link to HIV meds
Whether specific drugs such as tenofovir increase the risk, reduce the risk, or have a variable effect over time remains unclear.
Treatment 08/02/2012
NeurogesX patch for HIV pain might be ineffective, FDA staff report says
The FDA is scheduled to decide whether to approve Qutenza by March 7. The agency doesn’t have to follow the advisory panel’s recommendation.
Treatment 08/02/2012
Salix Pharmaceuticals announces FDA granting of Priority Review designation for the crofelemer NDA for treatment of diarrhea in patients with HIV/AIDS on anti-retroviral therapy
The FDA grants a Priority Review designation to drugs offering major advances in treatment, or providing a treatment where no adequate therapy exists.
Treatment 08/02/2012
HIV severity may influence mental health and academic ability in HIV-positive teens
HIV severity is associated with the severity of some mental health problems and academic, cognitive, and social impairments in teens born with HIV.
Treatment 07/02/2012
Rise of cancer in developing countries ‘linked to HIV’ says specialist
At least 30% of the cancers in developing countries are related to infection but HIV has emerged as a single major factor in the recent accelerated burden of cancer.
Treatment 06/02/2012
Spinal cord stimulation effective for HIV neuropathy
Constant spinal cord stimulation delivered through a permanently implanted device can offer pain relief to patients with HIV-related polyneuropathy that is refractory to conservative treatment.
Treatment 06/02/2012
New BHIVA guidelines recommend discussion with all patients on potential of HIV treatment to protect sexual partners
Treatment should be offered in circumstances where patients are concerned about the risk of transmitting HIV to partners – even if they are not in a serodiscordant relationship at the time.
Treatment 02/02/2012
Isentress, Intelence, Prezista regimen goes the distance for HIV treatment veterans
In treatment-experienced patients, an antiretroviral regimen containing raltegravir, etravirine and darunavir/ritonavir shows high efficacy, with a good safety profile.
Treatment 01/02/2012
HIV care providers in US struggling to cope with rising patient numbers
There is an increased need to train more primary care providers in HIV care. Coordinated, national efforts are required to built infrastructure, increase access points, and enhance provider capabilities to help ensure that patients get quality HIV care.
Treatment 31/01/2012
California study underscores the need to reduce cancer risk
Among HIV-positive people the risk for some cancers is elevated, though in some cases low CD4+ counts play a role in intensifying susceptibility to cancer.
Treatment 29/01/2012
Head, neck cancer treatment of less benefit for HIV patients
Conventional therapy for head and neck cancer appeared more toxic and less effective for patients with co-existing HIV infection.
Treatment 26/01/2012
Early antiretrovirals boost immune response in HIV infants
Infants with perinatal HIV infection should start antiretroviral therapy before three months of age.
Treatment 25/01/2012
Virologic failure on rilpivirine may lead to broad NNRTI resistance
In the ECHO and THRIVE trials, 10% of the patients who received rilpivirine-based regimens experienced treatment failure. Nearly half of these patients developed resistance to multiple nonnucleoside reverse transcriptase inhibitors.
Treatment 24/01/2012
Gilead initiates Phase 2 clinical trial evaluating GS-7340, a low-dose novel prodrug of tenofovir for the treatment of HIV
Phase 2 study will examine GS-7340 as part of a new once-daily, single-tablet regimen.
Treatment 24/01/2012
Face fillers and dental work—caution needed
HIV-positive people who have facial implants should always remind their oral health care professionals, including dentists, hygienists and surgeons, about the presence of such implants prior to receiving any oral care.
Treatment 24/01/2012
Smoking cessation counselling and treatment during routine HIV care helps patients to quit
Smoking cessation should be a topic of discussion in any physician-patient contact.
Treatment 24/01/2012
English public health indicators to include late HIV diagnosis
The Department of Health this week announced the 66 ‘indicators’ with which the performance of the new public health system will be measured.
More...
